In type 2 diabetes with chronic kidney disease, semaglutide slowed kidney-disease progression by about 24%. One milligram is a modest weight-loss dose but a proven kidney dose for that population
External resources STEP 1 Trial Extension: Weight regain after semaglutide withdrawal (PMC) Mayo Clinic: Semaglutide side effects and dosage information GI tolerability of semaglutide 2.4 mg in adults with overweight or obesity (PMC) In case I do not see you, good afternoon, good evening, and good night
While further research has to be conducted to solidify the link between cognition and IGF-1, IGF-1 has been proven to act at AMPARs to initiate changes in synaptic structure and protein expression
Rapid fat mobilization releases stored inflammatory compounds
Kindlin-3 is essential for integrin activation and platelet aggregation
As we age, NAD+ levels drop, leading to fatigue, inflammation, and brain fog